Previous close | 102.80 |
Open | 97.02 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 97.02 - 97.02 |
52-week range | 97.02 - 97.02 |
Volume | 144 |
Avg. volume | N/A |
Market cap | 62.326B |
Beta (5Y monthly) | 0.77 |
PE ratio (TTM) | 48.32 |
EPS (TTM) | 2.01 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Zacks Industry Outlook Highlights: Prologis, Extra Space Storage and Alexandria Real Estate Equities
3 Equity REIT Stocks Poised to Escape Pandemic-Led Industry Weakness
Abbott Laboratories (NYSE: ABT) is one of the most consistent growth stocks you'll find in the sector. The highly diversified seller of medical devices, diagnostics, pharmaceuticals for emerging market countries, and nutrition products puts together one solid quarter after another and hasn't had an earnings disappointment in over a decade. Abbott's fourth-quarter results got a big boost from COVID-19 testing.